Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Philip Rye
Introduction
Philip Rye is a notable inventor based in Eiksmarka, Norway. He has made significant contributions to the field of biomedical applications through his innovative work with alginate oligomers. With a total of 4 patents to his name, Rye's inventions focus on improving health outcomes in various clinical settings.
Latest Patents
Rye's latest patents include groundbreaking research on the use of alginate oligomers as blood anticoagulants. This invention relates to an alginate oligomer composed of 2 to 75 monomer residues, which do not carry a sulphate group. It is designed for use as a blood anticoagulant in clinical and non-clinical applications, including in vivo, ex vivo, and in vitro contexts. Additionally, he has developed alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract. This method involves administering an effective amount of an alginate oligomer to subjects in need, showcasing his commitment to advancing medical treatments.
Career Highlights
Philip Rye is currently associated with Algipharma AS, where he continues to innovate and develop new applications for his research. His work has garnered attention in the scientific community, particularly for its potential to improve patient care and treatment options.
Collaborations
Rye collaborates with fellow researcher Arne Dessen, contributing to the advancement of their shared goals in the field of biomedical research.
Conclusion
Philip Rye's contributions to the field of biomedical applications through his innovative patents highlight his dedication to improving health outcomes. His work with alginate oligomers represents a significant advancement in medical science, showcasing the potential for future developments in this area.